I-Omnipod ye-5 yeSikhokelo soMsebenzisi weSikhokelo sokuSebenzisa se-Insulin esingenaManzi

I-Pod kunye ne-Dexcom G6 iboniswe ngaphandle kokunamathela okuyimfuneko. I-Dexcom G6 ithengiswa ngokwahlukeneyo kwaye ifuna umyalelo owahlukileyo.

Iingcebiso eziluncedo zokuthetha nogqirha wakho malunga ne-Omnipod 5
I-Omnipod 5 yeyokuqala kunye ne-tubeless kuphela, i-waterproof * inkqubo yokuhanjiswa kwe-insulin ezenzekelayo e-US. Ilungisa ngokuzenzekelayo ukuhanjiswa kwe-insulin ukulawula ixabiso le-glucose yegazi imini nobusuku.

Ukugqiba ngonyango oluchanekileyo lweswekile kunokuba sisigqibo esikhulu, kwaye akufuneki uzenzele wedwa. Sebenzisa esi sikhokelo ukuba nengxoxo kunye nomboneleli wakho wezempilo ukufumanisa ukuba i-Omnipod 5 ilungile kuwe.

Zive ukhululekile ukuyiprinta kwaye uze nayo kwidinga lakho elilandelayo okanye uyithumele kumboneleli wakho wezempilo kwangaphambili.

Usenemibuzo?
Iingcali zethu ze-Omnipod zilapha ukunceda. Batsalele umnxeba namhlanje ngo 1-800-591-9948.

* I-Pod inomlinganiselo we-IP28 ukuya kuthi ga kwi-25 yeenyawo kwimizuzu engama-60. UMlawuli we-Omnipod 5 kunye noMphathi weSifo seswekile (PDM) akanamanzi. I-sensor ye-Dexcom G6 kunye ne-transmitter ayinamanzi kwaye inokuthi ifakwe phantsi kweenyawo ezisibhozo zamanzi ukuya kwiiyure ze-24 ngaphandle kokusilela xa ifakwe ngokufanelekileyo.

† Uluhlu lwezixhobo ze-smartphone ezihambelanayo tyelela omnipod.com/compatibility

1. Uphononongo kubantu abangama-240 abane-T1D abaneminyaka eyi-6 - 70 iminyaka ebandakanya iiveki ezi-2 zonyango oluqhelekileyo lweswekile olulandelwa ziinyanga ze-3 i-Omnipod 5 yokusetyenziswa kwiMowudi ezenzekelayo. Ixesha eliphakathi kunye ne-glucose ephezulu yegazi kubantu abadala / abaselula kunye nabantwana, unyango oluqhelekileyo kunye ne-3-inyanga ye-Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Ixesha eliphakathi kunye ne-glucose ephantsi yegazi kubantu abadala / abaselula kunye nabantwana, unyango oluqhelekileyo vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. UBrown et al. Ukhathalelo lwesifo seswekile (2021).
2. Uphononongo kubantu abangama-80 abane-T1D abaneminyaka eyi-2 ukuya kwi-5.9 iminyaka ebandakanya iiveki ezi-2 zonyango oluqhelekileyo lweswekile olulandelwa ziinyanga ze-3 i-Omnipod 5 yokusetyenziswa kwiMowudi ezenzekelayo. Ixesha eliphakathi kunye ne-glucose ephezulu yegazi (> 180mg / dL) ukusuka kwi-CGM kunyango oluqhelekileyo vs i-Omnipod 5 = 39.4% vs. 29.5%. Ixesha eliqhelekileyo kunye ne-glucose ephantsi yegazi (<70mg / dL) ukusuka kwi-CGM kunyango oluqhelekileyo vs i-Omnipod 5 = 3.41% vs. 2.13%. USherr JL, et al. Ukhathalelo lwesifo seswekile (2022).
3. Uphononongo kwi-128 yabantu abane-T1D abaneminyaka eyi-14 - 70 iminyaka ebandakanya iiveki ze-2 unyango oluqhelekileyo lwesifo sikashukela lulandelwa ziinyanga ze-3 i-Omnipod 5 yokusetyenziswa kwiMowudi ezenzekelayo. Ixesha eliqhelekileyo kwi-Target Glucose range (ukusuka kwiCGM) yonyango oluqhelekileyo vs i-Omnipod 5 kubantu abadala / abaselula = 64.7% vs. 73.9%. UBrown et al. Ukhathalelo lwesifo seswekile (2021).
4. Uphononongo kubantu abayi-112 abane-T1D abaneminyaka eyi-6 ukuya kwi-13.9 iminyaka ebandakanya iiveki ezi-2 zonyango oluqhelekileyo lweswekile olulandelwa ziinyanga ze-3 i-Omnipod 5 esetyenziswa kwiMowudi ezenzekelayo. Ixesha eliqhelekileyo kwi-Target Glucose range (ukusuka kwiCGM) yonyango oluqhelekileyo vs i-Omnipod 5 kubantwana = 52.5% vs 68.0%. UBrown S. et al. Ukhathalelo lwesifo seswekile (2021).
5. Uphononongo kubantu abangama-80 abane-T1D abaneminyaka eyi-2 ukuya kwi-5.9 iminyaka ebandakanya iiveki ezi-2 zonyango oluqhelekileyo lweswekile olulandelwa ziinyanga ze-3 i-Omnipod 5 yokusetyenziswa kwiMowudi ezenzekelayo. Ixesha eliqhelekileyo kwi-Target Glucose range (12AM -< 6AM) ukusuka kwiCGM kunyango oluqhelekileyo vs. Omnipod 5 = 58.2% vs 81.0%. USherr JL, et al. Ukhathalelo lwesifo seswekile (2022).

Nalu ulwazi oluluncedo xa ugcwalisa ummiselo we-Omnipod 5.

I-Omnipod isebenzisana ne-ASPN Pharmacies eya kulungelelanisa ukuzaliseka kunye nesigulane sakho kwikhemesti yabo yokuzikhethela. Xa i-e-prescribing nceda ungenise imimiselo kwi-ASPN Pharmacies.

Inqaku laBasebenzi baseOfisini: Nje ukuba izibonelelo zifunyenwe, abaguli banokundwendwela omnipod.com/setup ukuqalisa ukuseta isixhobo kunye nokucwangcisa uqeqesho lwabo.

Ingcali yeKhemesti ye-Omnipod iyafumaneka ukuze ikuncede wena kunye nabasebenzi beofisi yakho ngee-PAs okanye izibheno, ukuba ziyafuneka.
Ukuqhagamshelana neNgcali, tsalela umnxeba 1-866-347-0036

I-Insulet • 100 Nagog Park, Acton, MA 01720 • 1-800-591-3455 • omnipod.com
6. Uphononongo kwi-80 yabantu abane-T1D abaneminyaka eyi-2 - i-5.9 yrs ebandakanya iiveki ze-2 unyango oluqhelekileyo lwesifo sikashukela lulandelwa yi-3 iinyanga ze-Omnipod 5 kwi-Mode ezenzekelayo. Ixesha eliqhelekileyo kwi-Target Glucose range (12AM -< 6AM) ukusuka kwiCGM kunyango oluqhelekileyo vs. Omnipod 5 = 58.2% vs 81.0%. USherr JL, et al. Ukhathalelo lwesifo seswekile (2022).
7. Uphononongo kubantu be-128 abane-T1D abaneminyaka eyi-14 - 70 iminyaka ebandakanya iiveki ze-2 unyango oluqhelekileyo lwesifo sikashukela lulandelwa yi-3 iinyanga ze-Omnipod 5 kwi-Mode ezenzekelayo. Ixesha eliphakathi kunye ne-glucose yegazi ephantsi (ukusuka kwi-CGM) yonyango oluqhelekileyo vs i-Omnipod 5 = 2.00% vs 1.09%. UBrown S. et al. Ukhathalelo lwesifo seswekile (2021).
8. Uphononongo kubantu abangama-240 abane-T1D abaneminyaka eyi-6 - 70 iminyaka ebandakanya iiveki ze-2 unyango oluqhelekileyo lwesifo sikashukela lulandelwa ziinyanga ze-3 i-Omnipod 5 isetyenziswe kwiModi yokuSebenza. Umyinge we-A1c kubantu abadala / abaselula kunye nabantwana, unyango oluqhelekileyo ngokumelene ne-Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. UBrown S. et al. Ukhathalelo lwesifo seswekile (2021).
§ Ingqiqo yeklinikhi kufuneka ibonelelwe kwiinguqu zePod ezenzeka rhoqo ngaphezu kwe-72 hrs.
©2023 Insulet Corporation. I-Omnipod, ilogo ye-Omnipod, kunye ne-Simplify Life ziimpawu zorhwebo okanye iimpawu zorhwebo ezibhalisiweyo ze-Insulet Corporation e-United States of America kunye neminye imimandla eyahlukeneyo yolawulo. Onke Amalungelo Agciniwe. Ukusetyenziswa kweempawu zorhwebo zeqela lesithathu akuthethi ukuqinisekiswa okanye kuthetha ubudlelwane okanye enye indibaniselwano. INS-OHS-11-2022-00061 v1.0

 

Funda ngakumbi ngale ncwadana & Khuphela iPDF:

Amaxwebhu / Izibonelelo

I-Omnipod ye-5 ye-Automated ye-Insulin yokuThuthwa kwe-Insulin [pdf] Isikhokelo somsebenzisi I-5 ye-Automated ye-Insulin yokuThuthwa kwe-Insulin yokuThuthwa kwamanzi, iNkqubo yokuThuthwa kwe-Insulin yokuThuthwa kwamanzi, iNkqubo yokuThuthwa kwe-insulin ezenzekelayo, iNkqubo yokuThuthwa kwe-insulin

Iimbekiselo

• Incwadi yokusebenzisa